產(chǎn)品詳情
簡(jiǎn)單介紹：
Anti-HIP2抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購(gòu)！我公司長(zhǎng)期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-HIP2抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-HIP2
Cat. Number:
Anti-HIP2抗體KL-8379R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Accepts ubiquitin from the E1 complex and catalyzes its covalent attachment to other proteins. In vitro, in the presence or in the Anti-HIP2抗體absence of BRCA1-BARD1 E3 ubiquitin-protein ligase complex, catalyzes the synthesis of 'Lys-48'-linked polyubiquitin chains. Does not transfer ubiquitin directly to but elongates monoubiquitinated substrate protein. Mediates the selective degradation of short-lived and abnormal proteins, such as the endoplasmic reticulum-associated degradation (ERAD) of misfolded lumenal proteins. Ubiquitinates huntingtin. May mediate foam cell formation by the suppression of apoptosis of lipid-bearing macrophages through ubiquitination and subsequence degradation of p53/TP53. Proposed to be involved in ubiquitination and proteolytic processing of NF-kappa-B; in vitro supports ubiquitination of NFKB1. In case of infection by cytomegaloviruses may be involved in the US11-dependent degradation of MHC class I heavy chains following their export from the ER to the cytosol. In case of viral infections may be involved in the HPV E7 protein-dependent degradation of RB1.
Also known as:
E2 25K; E2(25K); HIP-2; HuntingtinAnti-HIP2抗體 interacting protein 2; Huntingtin-interacting protein 2; HYPG; LIG; UBC1; UBE2K; UBE2K_HUMAN; Ubiquitin carrier protein; Ubiquitin conjugating enzyme E2 25 kDa; Ubiquitin conjugating enzyme E2-25 kDa; ubiquitin conjugating enzyme E2K; ubiquitin conjugating enzyme E2K (UBC1 homolog, yeast); Ubiquitin protein ligase; Ubiquitin-conjugating enzyme E2 K; Ubiquitin-conjugating enzyme E2(25K); Ubiquitin-conjugating enzyme E2-25 kDa; Ubiquitin-conjugating enzyme E2-25K; Ubiquitin-protein ligase.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Chicken, Dog, Pig, Cow, Rabbit, .
●
Immunogen: KLH conjugated syntheticAnti-HIP2抗體 peptide derived from human HIP2.
●
Predicted Molecular Weight: 22kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:50-200
Not yet tested in other applications. Anti-HIP2抗體
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications. Anti-HIP2抗體
Optimal working dilutions must be determined by the end user.
kl434Hu01 肌球蛋白ⅠE(MYO1E)多克隆抗體 Polyclonal Antibody to Myosin IE (MYO1E)
kl434Mu01 肌球蛋白ⅠE(MYO1E)多克隆抗體 Polyclonal Antibody to Myosin IE (MYO1E)
kl434Ra01 肌球蛋白ⅠE(MYO1E)多克隆抗體 Polyclonal Antibody to Myosin IE (MYO1E)
kl433Hu01 肌球蛋白ⅠD(MYO1D)多克隆抗體 Polyclonal Antibody to Myosin ID (MYO1D)
kl433Mu01 肌球蛋白ⅠD(MYO1D)多克隆抗體 Polyclonal Antibody to Myosin ID (MYO1D)
kl432Hu01 肌球蛋白ⅠC(MYO1C)多克隆抗體 Polyclonal Antibody to Myosin IC (MYO1C)
kl432Mu01 肌球蛋白ⅠC(MYO1C)多克隆抗體 Polyclonal Antibody to Myosin IC (MYO1C)
kl432Ra01 肌球蛋白ⅠC(MYO1C)多克隆抗體 Polyclonal Antibody to Myosin IC (MYO1C)
kl431Hu01 肌球蛋白ⅠB(MYO1B)多克隆抗體 Polyclonal Antibody to Myosin IB (MYO1B)
kl431Mu01 肌球蛋白ⅠB(MYO1B)多克隆抗體 Polyclonal Antibody to Myosin IB (MYO1B)
kl431Ra01 肌球蛋白ⅠB(MYO1B)多克隆抗體 Polyclonal Antibody to Myosin IB (MYO1B)
kl375Hu01 肌球蛋白ⅠA(MYO1A)多克隆抗體 Polyclonal Antibody to Myosin IA (MYO1A)
kl375Mu01 肌球蛋白ⅠA(MYO1A)多克隆抗體 Polyclonal Antibody to Myosin IA (MYO1A)
kl375Ra01 肌球蛋白ⅠA(MYO1A)多克隆抗體 Polyclonal Antibody to Myosin IA (MYO1A)
kl604Hu01 載脂蛋白A2(APOA2)多克隆抗體 Polyclonal Antibody to Apolipoprotein A2 (APOA2)
kl604Mu01 載脂蛋白A2(APOA2)多克隆抗體 Polyclonal Antibody to Apolipoprotein A2 (APOA2)
kl604Ra01 載脂蛋白A2(APOA2)多克隆抗體 Polyclonal Antibody to Apolipoprotein A2 (APOA2)
kl153Hu01 甲胎蛋白(αFP)多克隆抗體 Polyclonal Antibody to Alpha-Fetoprotein (aFP)
